The reality is that antibiotics and similar medicines are mostly sold to Monopsonistic governments and don’t represent the profit base of big Pharma. Instead they have focussed on products such as Prozac that are high-profit by their nature, while thirty-year old antibiotics are left to become ever less effective against evolving viruses. [i] .  [i] Gouge, Deborah, ‘Big Pharma Abandons Antibiotics: An Opening For Small Biotech’, Seeking Alpha, 13 May 2012.
